- Integer has entered into a definitive agreement under which KKR will acquire the medical device CDMO in an all-cash transaction with an enterprise value of approximately $5.7 billion.
- The transaction values Integer at $127 per share and is expected to close by the end of 2026, subject to shareholder and regulatory approvals.
Integer Holdings Corporation has entered into a definitive agreement to be acquired by an affiliate of investment funds managed by KKR in an all-cash transaction valued at an enterprise value of approximately $5.7 billion. Under the agreement, Integer stockholders will receive $127 per share, representing a 51.8% premium to the company’s closing share price on April 29, 2026, and a 28.8% premium to the 30-day volume-weighted average price as of July 31, 2026. Upon completion of the transaction, the medical device contract development and manufacturing organization (CDMO) will become a privately held company and its common stock will no longer trade on the New York Stock Exchange.
The agreement follows the strategic review announced by Integer on April 30, 2026. According to the company, its board evaluated a range of alternatives and concluded that the transaction with KKR provided the best path forward while delivering immediate value to stockholders. The acquisition is expected to close by the end of the year, subject to customary closing conditions, including shareholder approval and regulatory clearances. The transaction is not subject to a financing contingency.
“This is an exciting milestone for Integer and a testament to the dedication and commitment of our talented team and the exceptional business we have built together. We believe this transaction recognizes the strength of Integer’s business, which includes our dedicated associates, our differentiated engineering and manufacturing capabilities, and our long-term growth opportunities, while providing stockholders with immediate and certain value.”
Payman Khales, President and CEO of Integer
KKR said it plans to finance the acquisition through a combination of equity from investment funds it manages and committed debt financing. Following completion of the transaction, KKR intends to invest in Integer’s manufacturing capacity, technology, innovation, and talent, while establishing a broad-based employee ownership and engagement program.
Separately, Integer reported its second-quarter 2026 financial results. In light of the pending acquisition, the company said it is withdrawing its previously issued financial outlook and will not hold the earnings conference call and webcast that had been scheduled for August 6, 2026.
